ALZNHIGH SIGNALFINANCIAL10-K

ALZN dramatically improved its financial position with cash increasing 950% to $3.9M and achieving positive stockholders' equity of $4.0M after eliminating most liabilities.

This represents a fundamental transformation of the company's capital structure, likely through significant equity financing that has temporarily resolved immediate liquidity concerns. However, the company continues burning cash with operating losses of $4.5M, and the massive increase in current liabilities to $2.9M suggests new financial obligations that warrant close monitoring.

Comparing 2025-07-22 vs 2024-07-30View on EDGAR →
FINANCIAL ANALYSIS

ALZN underwent a dramatic financial restructuring with cash surging 950% to $3.9M and total assets growing 629% to $4.6M, while simultaneously reducing total liabilities by 80% and achieving positive stockholders' equity of $4.0M from a previous deficit of $2.6M. R&D expenses dropped significantly by 78% to $1.4M, contributing to a 55% improvement in operating losses to $4.5M. The overall picture suggests a major capital raise that has stabilized the balance sheet in the near term, though current liabilities increased 146% to $2.9M, indicating new financial commitments that could pressure future cash flows.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
+950%
$376K$3.9M

Cash position surged 950% — strong cash generation or capital raise providing significant financial cushion.

Current Assets
Balance Sheet
+817.6%
$455K$4.2M

Current assets grew 817.6% — improving short-term liquidity or inventory/receivables build.

Total Assets
Balance Sheet
+628.8%
$632K$4.6M

Asset base grew 628.8% — expansion through organic growth, acquisitions, or capital deployment.

Stockholders Equity
Balance Sheet
+253%
-$2.6M$4.0M

Equity base grew 253% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Current Liabilities
Balance Sheet
+146.4%
$1.2M$2.9M

Current liabilities surged 146.4% — significant near-term obligations; verify ability to meet short-term debt.

Total Liabilities
Balance Sheet
-80.3%
$3.2M$635K

Liabilities reduced 80.3% — deleveraging improves balance sheet strength and financial flexibility.

Interest Expense
P&L
+78.5%
$10K$18K

Interest expense surged 78.5% — significant debt increase or rising rates materially impacting earnings.

R&D Expense
P&L
-78.1%
$6.5M$1.4M

R&D spending cut 78.1% — could signal cost discipline or concerning reduction in innovation investment.

Operating Income
P&L
+54.7%
-$9.9M-$4.5M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Net Income
P&L
+54.6%
-$9.9M-$4.5M

Net income grew 54.6% — bottom-line growth signals improving overall business health.

LANGUAGE CHANGES
NEW — 2025-07-22
PRIOR — 2024-07-30
ADDED
If we fail to comply with our obligations in the agreements under which we license intellectual property and other rights from third parties or otherwise experience disruptions to our business relationships with the University of South Florida Research Foundation, we could lose license rights that are important to our business.
If we do not continue to satisfy the Nasdaq Capital Market continued listing requirements, our common stock could be delisted from the Nasdaq Capital Market.
Far too many individuals, including patients and caregivers, suffer from the burden created by these devastating, and often fatal, diseases.
Alzheimer s is also the seventh leading cause of death (in 2021 and 2022) in the United States ( U.S.
will be $384 billion, including $246 billion in Medicare and Medicaid payments.
+7 more — sign up free →
REMOVED
If we fail to comply with our obligations in the agreements under which we license intellectual property and other rights from third parties or otherwise experience disruptions to our business relationships with the Licensor, we could lose license rights that are important to our business.
If we do not regain compliance with or continue to satisfy the Nasdaq Capital Market continued listing requirements, our common stock could be delisted from the Nasdaq Capital Market.
The concentration of our stock ownership will limit your ability to influence corporate matters, including the ability to influence the outcome of director elections and other matters requiring stockholder approval.
Far too many individuals, patients and caregivers suffer from the burden created by these devastating, and often fatal, diseases.
Alzheimer s is also the seventh leading cause of death (in 2020 and 2021) in the United States ( U.S.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →